News Tipped to hit $1bn, GSK’s Shingrix gains committee approval GlaxoSmithKline’s shingles vaccine Shingrix has gained the unanimous backing of an FDA advisory committee.
News Sanofi $750m acquisition gives it edge in flu vacccine marke... Biotech's Flublok is only FDA-approved cell-based flu jab
News UK space plans take flight - and medicines could benefit Government hopes spaceport plans will boost biotech research
News Sanofi Pasteur and MSD end vaccines joint venture Companies end collaboration after more than 20 years.
Articles What doctors say about the Meningitis B vaccination Will Moore examines the reaction of the public and healthcare providers to the high-profile news of a two-year-old who died from Meningitis B infection and subsequent demands for more widesprea
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
